Attached files

file filename
EX-10.3 - REGISTRATION RIGHTS AGREEMENT - Arrowroot Acquisition Corp.nt10018729x9_ex10-3.htm
EX-10.6 - INDEMNITY AGREEMENT - Arrowroot Acquisition Corp.nt10018729x9_ex10-6.htm
EX-10.5 - ADMINISTRATIVE SERVICES AGREEMENT - Arrowroot Acquisition Corp.nt10018729x9_ex10-5.htm
EX-10.4 - LETTER AGREEMENT - Arrowroot Acquisition Corp.nt10018729x9_ex10-4.htm
EX-10.2 - INVESTMENT MANAGEMENT TRUST AGREEMENT - Arrowroot Acquisition Corp.nt10018729x9_ex10-2.htm
EX-10.1 - PRIVATE PLACEMENT WARRANT PURCHASE AGREEMENT - Arrowroot Acquisition Corp.nt10018729x9_ex10-1.htm
EX-4.1 - WARRANT AGREEMENT - Arrowroot Acquisition Corp.nt10018729x9_ex4-1.htm
EX-3.1 - AMENDED AND RESTATED CERTIFICATE OF INCORPORATION - Arrowroot Acquisition Corp.nt10018729x9_ex3-1.htm
EX-1.1 - UNDERWRITING AGREEMENT - Arrowroot Acquisition Corp.nt10018729x9_ex1-1.htm


SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 4, 2021 (March 1, 2021)

 

ARROWROOT ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

 

 

         
Delaware   001-835972   85-3961600

(State or other jurisdiction of incorporation

or organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

   

4553 Glencoe Ave, Suite 200

Marina Del Rey, California

  90292
(Address of principal executive offices)   (Zip Code)

(310) 566-5966

Registrant’s telephone number, including area code

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant ARRWU The Nasdaq Stock Market LLC
Shares of Class A common stock included as part of the units ARRW The Nasdaq Stock Market LLC
Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 ARRWW The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


 

Item 1.01. Entry into a Material Definitive Agreement.

On March 1, 2021, the Registration Statement on Form S-1 (File No. 333-252997) (the “Registration Statement”) relating to the initial public offering (the “IPO”) of Arrowroot Acquisition Corp. (the “Company”) was declared effective by the U.S. Securities and Exchange Commission. On March 4, 2021 the Company consummated the IPO of 28,750,000 units (the “Units”), which includes the exercise in full of the underwriters’ option to purchase an additional 3,750,000 Units at the initial public offering price to cover over-allotments. Each Unit consists of one share of Class A common stock, $0.0001 par value per share (the “Common Stock”), and one-half of one redeemable warrant (the “Public Warrants”), each whole Public Warrant entitling the holder thereof to purchase one share of Common Stock at an exercise price of $11.50 per share, subject to adjustment. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $287,500,000. Further, in connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Registration Statement:

an Underwriting Agreement, dated March 1, 2021, between the Company and Cantor Fitzgerald & Co., as representative of the underwriters named in Schedule I therein, which contains customary representations and warranties and indemnification of the underwriter by the Company;
a Private Placement Warrants Purchase Agreement, dated March 1, 2021, between the Company and Arrowroot Acquisition LLC (the “Sponsor”), pursuant to which the Sponsor purchased 8,250,000 private placement warrants, each exercisable to purchase one share of Common Stock at $11.50 per share, subject to adjustment, at a price of $1.00 per warrant (the “Private Placement Warrants” and, together with the Public Warrants, the “Warrants”);
a Warrant Agreement, dated March 4, 2021, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (the “Warrant Agreement”), which sets forth the expiration and exercise price of and procedure for exercising the Warrants; certain adjustment features of the terms of exercise; provisions relating to redemption and cashless exercise of the Warrants; certain registration rights of the holders of Warrants; provision for amendments to the Warrant Agreement; and indemnification of the warrant agent by the Company under the agreement;
an Investment Management Trust Agreement, dated March 4, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee, which establishes the trust account that will hold the net proceeds of the IPO and certain of the proceeds of the sale of the Private Placement Warrants, and sets forth the responsibilities of the trustee; the procedures for withdrawal and direction of funds from the trust account; and indemnification of the trustee by the Company under the agreement;

 

 

 

a Registration Rights Agreement, dated March 4, 2021, among the Company, the Sponsor and certain equityholders of the Company, which provides for customary demand and piggy-back registration rights for the Sponsor, and customary piggy-back registration rights for such other equityholders, as well as certain transfer restrictions applicable to the Sponsor with respect to the Company’s securities;
a Letter Agreement, dated March 4, 2021, among the Company, the Sponsor and each executive officer and director of the Company, pursuant to which the Sponsor and each executive officer and director of the Company has agreed to vote any share of Common Stock held by him, her or it in favor of the Company’s initial business combination; to facilitate the liquidation and winding up of the Company if an initial business combination is not consummated within 24 months; to certain transfer restrictions with respect to the Company’s securities; to certain indemnification obligations of the Sponsor; and the Company has agreed not to enter into a definitive agreement regarding an initial business combination without the prior consent of the Sponsor;
an Administrative Services Agreement, dated March 4, 2021, between the Company and the Sponsor, pursuant to which the Sponsor has agreed to make available office space, secretarial and administrative services, as may be required by the Company from time to time, for $20,000 per month until the earlier of the Company’s initial business combination or liquidation; and
  an Indemnity Agreement, dated March 4, 2021, between the Company and each of the officers and directors of the Company, pursuant to which the Company has agreed to indemnify each officer and director of the Company against certain claims that may arise in their roles as officers and directors of the Company.

The above descriptions are qualified in their entirety by reference to the full text of the applicable agreement, each of which is incorporated by reference herein and filed herewith as Exhibits 1.1, 10.1, 4.1, 10.2, 10.3, 10.4, 10.5 and 10.6 respectively.

Item 3.02. Unregistered Sales of Equity Securities.

Simultaneous with the consummation of the IPO and the issuance and sale of the Units, the Company consummated the private placement of 8,250,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating total proceeds of $8,250,000 (the “Private Placement”). The Private Placement Warrants, which were purchased by the Sponsor, are substantially similar to the Public Warrants, except that if held by the Sponsor or its permitted transferees, they (i) may be exercised for cash or on a cashless basis, (ii) are not subject to being called for redemption (except in certain circumstances when the Public Warrants are called for redemption and a certain price per share of Common Stock threshold is met) and (iii) subject to certain limited exceptions, will be subject to transfer restrictions until 30 days following the consummation of the Company’s initial business combination. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by holders on the same basis as the Public Warrants. The Private Placement Warrants have been issued pursuant to and are governed by the Warrant Agreement.

Item 5.03. Amendments to Certificate of Incorporation.

On March 3, 2021 and in connection with the IPO, the Company adopted its Amended and Restated Certificate of Incorporation. The Amended and Restated Certificate of Incorporation is filed herewith as Exhibit 3.1 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

1.1 Underwriting Agreement between the Company and Cantor Fitzgerald & Co.

 

3.1 Amended and Restated Certificate of Incorporation

 

4.1 Warrant Agreement between Continental Stock Transfer & Trust Company and the Company

 

10.1 Private Placement Warrants Purchase Agreement between the Company and the Sponsor

 

10.2 Investment Management Trust Account Agreement between Continental Stock Transfer & Trust Company and the Company

 

10.3 Registration Rights Agreement among the Company, the Sponsor and certain other equityholders named therein

 

10.4 Letter Agreement among the Company, the Sponsor and the Company’s officers and directors

 

10.5 Administrative Services Agreement between the Company and the Sponsor

 

10.6
Indemnity Agreement among the Company and the Company’s officers and directors
 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: March 5, 2021 ARROWROOT ACQUISITION CORP.
     
  By: /s/ Matthew Safaii
  Name: Matthew Safaii
  Title: Chief Executive Officer